These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18989142)

  • 1. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases.
    Teschke R; Schwarzenboeck A; Hennermann KH
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1182-93. PubMed ID: 18989142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment.
    Teschke R; Fuchs J; Bahre R; Genthner A; Wolff A
    J Clin Pharm Ther; 2010 Oct; 35(5):545-63. PubMed ID: 20831679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava hepatotoxicity: a European view.
    Teschke R; Schwarzenboeck A; Akinci A
    N Z Med J; 2008 Oct; 121(1283):90-8. PubMed ID: 18841189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?
    Teschke R; Wolff A
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):1-7. PubMed ID: 20854865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kava hepatotoxicity: regulatory data selection and causality assessment.
    Teschke R; Wolff A
    Dig Liver Dis; 2009 Dec; 41(12):891-901. PubMed ID: 19477698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kava, kavapyrones and toxic liver injury].
    Teschke R
    Z Gastroenterol; 2003 May; 41(5):395-404. PubMed ID: 12772052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kava hepatotoxicity--a clinical review.
    Teschke R
    Ann Hepatol; 2010; 9(3):251-65. PubMed ID: 20720265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kava extracts: safety and risks including rare hepatotoxicity.
    Teschke R; Gaus W; Loew D
    Phytomedicine; 2003; 10(5):440-6. PubMed ID: 12834011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures.
    Teschke R; Genthner A; Wolff A
    J Ethnopharmacol; 2009 Jun; 123(3):378-84. PubMed ID: 19501269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Black cohosh hepatotoxicity: quantitative causality evaluation in nine suspected cases.
    Teschke R; Bahre R; Fuchs J; Wolff A
    Menopause; 2009; 16(5):956-65. PubMed ID: 19339903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Review "Kava, kavapyrones and toxic liver injury" by R Teschke, Hanau Zeitschrift für Gastroenterologie 2003, 41:395-404].
    Stickel F; Seitz HK; Schuppan D
    Z Gastroenterol; 2003 Aug; 41(8):888-9. PubMed ID: 12910431
    [No Abstract]   [Full Text] [Related]  

  • 12. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?
    Teschke R; Schmidt-Taenzer W; Wolff A
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):567-82. PubMed ID: 21702069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacovigilance and herbal hepatotoxicity: critical aspects and solutions].
    Teschke R; Schulze J
    Dtsch Med Wochenschr; 2013 Feb; 138(6):281-4. PubMed ID: 23361353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and causality assessment in herbal hepatotoxicity.
    Teschke R; Schwarzenboeck A; Eickhoff A; Frenzel C; Wolff A; Schulze J
    Expert Opin Drug Saf; 2013 May; 12(3):339-66. PubMed ID: 23458441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspected Greater Celandine hepatotoxicity: liver-specific causality evaluation of published case reports from Europe.
    Teschke R; Glass X; Schulze J; Eickhoff A
    Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):270-80. PubMed ID: 22189691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herbal hepatotoxicity: a tabular compilation of reported cases.
    Teschke R; Wolff A; Frenzel C; Schulze J; Eickhoff A
    Liver Int; 2012 Nov; 32(10):1543-56. PubMed ID: 22928722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation and the use of KAVA: Case report.
    Becker MW; Lourençone EMS; De Mello AF; Branco A; Filho EMR; Blatt CR; Mallmann CA; Schneider M; Caregnato RCA; Blatt CR
    Phytomedicine; 2019 Mar; 56():21-26. PubMed ID: 30668342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kava hepatotoxicity solution: A six-point plan for new kava standardization.
    Teschke R; Sarris J; Lebot V
    Phytomedicine; 2011 Jan; 18(2-3):96-103. PubMed ID: 21112196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kava hepatotoxicity: pathogenetic aspects and prospective considerations.
    Teschke R
    Liver Int; 2010 Oct; 30(9):1270-9. PubMed ID: 20630022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review.
    Teschke R
    Menopause; 2010 Mar; 17(2):426-40. PubMed ID: 20216279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.